+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tekturna"

Tekturna - API Insight, 2022 - Product Thumbnail Image

Tekturna - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Tekturna- Drug Insight, 2019 - Product Thumbnail Image

Tekturna- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Tekturna (also known as Rasilez) is a brand of cardiovascular drug used to treat high blood pressure. It is a direct renin inhibitor, meaning it works by blocking the action of the enzyme renin, which is responsible for the production of angiotensin II, a hormone that causes blood vessels to constrict. Tekturna is used in combination with other medications to reduce the risk of stroke, heart attack, and kidney problems in people with high blood pressure. It is also used to reduce the risk of death in people with heart failure. The Tekturna market is composed of a variety of pharmaceutical companies that produce and distribute the drug. These companies include Novartis, Mylan, and Teva Pharmaceuticals. Other companies involved in the market include Sandoz, Lupin, and Sun Pharmaceuticals. These companies are responsible for the production, distribution, and marketing of Tekturna. Show Less Read more